Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04303741 |
|---|---|
| Brief Title: | A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC |
| First Submitted : | March 7, 2020 |
| First Submitted that Met QC Criteria : | March 9, 2020 |
| First Posted : | March 11, 2020 |
| Last Update Submitted that Met QC Criteria : | April 10, 2023 |
| Last Update Posted : | April 12, 2023 |